Clinical Trial to Evaluate the Effect of a Probiotic Mixture on Signs and Symptoms of Irritable Bowel Syndrome - Trial NCT05565612
Access comprehensive clinical trial information for NCT05565612 through Pure Global AI's free database. This phase not specified trial is sponsored by Laboratorio Industrial de Herbodietetica Aplicada S.L and is currently Not yet recruiting. The study focuses on IBS - Irritable Bowel Syndrome. Target enrollment is 25 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Laboratorio Industrial de Herbodietetica Aplicada S.L
Timeline & Enrollment
N/A
Oct 01, 2022
Jun 01, 2023
Primary Outcome
Change from baseline on IBS-SSS (Irritable Bowel Syndrome-Severity Scoring System) scale at 4, 8 and 12 weeks
Summary
The clinical trial has a randomized, double-blind and placebo-controlled design, in which the
 effect of a probiotic mix wants to be evaluated, with a treatment of 12 weeks, in the
 evolution of the symptoms of Irritable Bowel Syndrome.
 
 The 12 weeks of the treatment are structured in four in-person visits: Visit 1 (initial; week
 0), Visit 2 (halfway; week 4), Visit 3 (halfway; week 8) and Visit 4 (final; week 12).
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05565612
Non-Device Trial